Clinical Trials
3 trialsNCT05583552 2026-05-12
IMpress
GCP-Service International West GmbH
Phase 2 Active not recruiting
NCT02598661 2026-01-05
Study to Evaluate Imetelstat (GRN163L) in Participants With International Prognostic Scoring System (IPSS) Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)
Geron Corporation
Phase 2/3 Active not recruiting
NCT01731951 2021-09-21
Imetelstat Sodium in Treating Participants With Primary or Secondary Myelofibrosis
Geron Corporation
Phase 2 Completed